Xencor
XNCR
#5470
Rank
โ‚น146.43 B
Marketcap
โ‚น1,975
Share price
8.72%
Change (1 day)
151.37%
Change (1 year)

Revenue for Xencor (XNCR)

Revenue in 2026 (TTM): โ‚น8.56 Billion

According to Xencor's latest financial reports the company's current revenue (TTM ) is โ‚น9.40 Billion. In 2025 the company made a revenue of โ‚น11.27 Billion an increase over the revenue in the year 2024 that were of โ‚น10.95 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Xencor from 2013 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น8.56 B-24.06%
2025 โ‚น11.27 B2.89%
2024 โ‚น10.95 B-21.82%
2023 โ‚น14.01 B2.9%
2022 โ‚น13.61 B-33.49%
2021 โ‚น20.47 B128.2%
2020 โ‚น8.97 B-19.7%
2019 โ‚น11.17 B293.6%
2018 โ‚น2.83 B65.05%
2017 โ‚น1.72 B-71.08%
2016 โ‚น5.94 B222.37%
2015 โ‚น1.84 B205.78%
2014 โ‚น0.60 B-3.99%
2013 โ‚น0.62 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚น9.306 T 98,874.94%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น6.067 T 64,422.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น3.594 T 38,129.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น6.351 T 67,451.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
โ‚น222.16 B 2,262.73%๐Ÿ‡บ๐Ÿ‡ธ USA
MacroGenics
MGNX
โ‚น15.17 B 61.34%๐Ÿ‡บ๐Ÿ‡ธ USA